Home  »  Equity Investing   »  OrganiGram Holdings Inc. (OGI) stock plunges in th...

OrganiGram Holdings Inc. (OGI) stock plunges in the current market trading. Here’s to know why?

OrganiGram Holdings Inc. (OGI) stock declines by 8.75% in the current market trading.  Organigram is focused on growing high-quality, indoor-grown cannabis for Canadian patients and adult recreational users, as well as forming foreign commercial relationships to expand the company’s global presence. The Edison Cannabis Company, Indi, Bag o’ Buds, SHRED, and Trailblazer are among the adult-use recreational cannabis products produced by Organigram

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Recent Development

Financial Results

On April 13, 2021, OGI has reported its second-quarter fiscal 2021 financial results. Given below is the summary:

  • The decline in net revenue from Q2 2020 to Q2 2021 was largely attributed to lower wholesale revenue and a lower effective selling price in Q2 2021. Owing to lost business opportunities as a result of some workers testing positive for COVID-19, a large amount of facility personnel had to isolate in Q2 2021, net income was also smaller.
  • Higher Q2 2021 cost of sales was largely characterized by higher inventory provisions, a higher cost of revenue, and a charge attributable to unabsorbed fixed overhead as a result of lower Q2 2021 production levels.
  • Because of the negative Q2 2021 gross margin before fair value changes to biological properties, inventories sold, and other costs as mentioned above, as well as net non-cash negative fair value shifts to biological assets and inventories sold in Q2 2021 versus positive changes in Q2 2020, Q2 2021 gross margin was negative relative to positive Q2 2020 gross margin.
  • Negative adjusted EBITDA in Q2 2021 fell from positive adjusted EBITDA in Q2 2020, owing to lower adjusted gross margin in Q2 2021.
  • The unfavorable improvement in the market valuation of the derivative warrant obligations and the negative operating margin in Q2 2021 contributed to a higher net loss in Q2 2021 than in Q2 2020.

Liquidity and Capital Resources

  • OGI repaid all revolving balances under its credit arrangement with BMO and a syndicate of lenders on April 1, 2021, preserving $2.7 million in annual interest (based on the outstanding balance at the time of repayment).
  • As of now, OGI has $232 million in liquidity and short-term deposits on hand.
  • Currently, Organigram plans to terminate the Credit Agreement and release the associated protections.

Leave a Comment

Your email address will not be published. Required fields are marked *

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Biotech Stocks to Buy for Sep-2021

Biotechnology (biotech) refers to the use of microbes and cellular biology in health-related research and development. It is not just therapies that biotechnology companies develop.




Download Free eBook For


100% free. stop anytime no spam